STRIDE Study Aims for Better Treatments for Children With IBD
Published
Featured Researchers
This month, Seattle Children’s, in partnership with the Allen Institute for Immunology, launched a first-of-its-kind clinical study to better understand how and why inflammatory bowel disease (IBD) begins, with the ultimate goal to provide targeted therapies to children who suffer from IBD.
IBD — which includes Crohn’s disease and ulcerative colitis — is a lifelong condition with no current cures; once a person begins treatment, they continue treatment indefinitely. The symptoms of IBD can negatively impact children’s growth and mental health, and lead to missed school and social activities.
Approximately 30% of pediatric IBD patients do not respond to initial treatment and nearly half of patients ultimately lose response over time. Children with IBD typically must try multiple treatment and medication options over time to find one that works best.
The Seattle STRIDE study is the first pediatric trial to deploy novel techniques (single cell spatial transcriptomics and single cell multi-omics) to understand how genes and other molecules behave in individual cells of patients who haven't been treated yet.
Researchers hope that the information gained from Seattle STRIDE study will not only improve treatment options, but also inform the decisions of how to treat individual patients, reducing the number of treatments patients must undergo.
The STRIDE study is led by Dr. Hengqi (Betty) Zheng and Dr. David Suskind of the Center for Clinical and Translational Research, co-principal investigator.
The trial is recruiting participants ages 6 to 18 years old over a three-year period. Learn more about the STRIDE study.
A piece of large intestine, biopsied from a pediatric IBD patient, reveals cellular and molecular features used to understand disease activity. These include epithelial cells (green), muscle (dark blue), T cells (lavender and purple), B cells (yellow), monocytes and macrophages (cyan), and cells actively dividing (red). Credit: Jocelin Malone
Related Categories
Featured Researchers
Focus Areas Links
Related Centers & Programs
Related Articles
Publication Q&A: Targeting a Site of Vulnerability to Inhibit Plasmodium vivax Malaria
Published
Researchers discovered a new weak spot on the Plasmodium vivax malaria parasite and identified a potent antibody that blocks it. These findings lay the groundwork for next-generation vaccines to prevent infection and help eliminate malaria globally.
Publication Q&A: Preterm Birth Alters the Natural Timing of Brain Development
Published
A new study co-led by Dr. Vittorio Gallo in Science reveals that premature birth alters the natural timing of brain development. Learn how mapping cell-level changes will help doctors deliver personalized care for preterm infants.
Publication Q&A: Mobile Subthreshold Exercise Program (MSTEP) for Youth With Prolonged Concussion Recovery
Published
New research led by Dr. Sara Chrisman demonstrates that a 6-week virtual aerobic exercise program (MSTEP) significantly speeds up youth concussion recovery.